Pet Food and Nutrition

Critique on Senior Dog Food Study: Fresh vs. Kibble

A recent study investigating the health impacts of fresh, human-grade dog food compared to conventional kibble in older canines has come under scrutiny from BSM Partners. This metabolomic research, initially suggesting fresh food promotes healthier aging, faces significant challenges regarding its methodology, data accuracy, and overall conclusions. BSM Partners' detailed critique highlights several areas of concern, including the confounding variables in the study's design, mathematical inaccuracies in nutritional reporting, and a lack of transparency concerning crucial experimental details. These issues cast doubt on the initial findings and emphasize the importance of rigorous scientific standards in pet nutrition research.

The study, led by Dr. Heather Huson from Cornell University, in collaboration with veterinary nutritionists from The Farmer's Dog, aimed to assess how different diets influence the metabolic health of 22 senior dogs over a year. While the study concluded that fresh, minimally processed food could positively impact metabolic health and support longevity, BSM Partners' analysis suggests these conclusions might be flawed due to several critical issues.

One of the primary concerns raised by BSM Partners is the study's confounded design. The two diets—fresh food and kibble—differed not only in their processing methods but also significantly in their nutritional composition. The fresh food contained higher levels of protein and fat, substantially fewer carbohydrates, and added Omega-3 fatty acids, making it difficult to ascertain whether observed health outcomes were due to the processing method or the distinct nutrient profiles. Furthermore, the kibble used was an experimental diet, not reflective of commercially available products, which limits the applicability of the findings to real-world scenarios.

BSM Partners also identified what they describe as widespread mathematical errors within the study's nutrient tables. For example, vitamin A and copper levels were reportedly listed at concentrations far exceeding safe limits set by the Association of American Feed Control Officials (AAFCO), potentially posing toxicity risks to dogs. Similar discrepancies were found for other minerals like iron, zinc, and manganese, with reported levels being 50 to 100 times higher than AAFCO's minimum nutritional requirements.

Transparency in methodology was another key point of contention. BSM Partners noted that the study failed to provide essential details on how the diets were prepared, including cooking methods, durations, and temperatures. Information regarding food intake or consumption by the participating dogs was also omitted. Crucially, the research did not clarify whether nutrient levels were laboratory-tested or merely calculated, which is vital for data reliability. Additionally, some dogs received various medications during the study, yet the timing, dosages, and corresponding diets were not clearly documented, potentially interfering with blood chemistry results and confounding the study's outcomes.

The definition of 'fresh' food as presented in the study also sparked debate. BSM Partners argues that the test diet, being heat-cooked and packaged for safety and shelf stability, does not align with the FDA and AAFCO's definition of fresh, which typically refers to food in its raw state, preserved only by simple refrigeration. This misclassification further undermines the study's claims about the benefits of 'fresh' food.

Finally, BSM Partners expressed reservations about the peer-review process itself, suggesting that studies with significant flaws can sometimes be published, particularly in newer or less stringent journals. They highlighted that despite the systematic mathematical errors, confounded design, and missing methodological details, this study managed to pass peer review, indicating a potential lapse in the oversight process.

Akston Initiates Clinical Study for Feline Weight Management Therapy at Cornell

Akston, a leader in protein therapeutics for pets, has commenced a pivotal clinical study at Cornell University's College of Veterinary Medicine. This trial focuses on their innovative once-weekly GLP-1 therapy, designed to combat the pervasive issue of excess weight in felines.

Revolutionizing Feline Health: A Breakthrough in Weight Management

Pioneering a Novel Approach to Feline Weight Management

Akston has officially begun a clinical study at Cornell University's College of Veterinary Medicine. This trial is set to evaluate a groundbreaking once-weekly GLP-1 therapy specifically formulated for managing weight in cats. The study will involve domestic cats with overweight conditions, observed over a period of approximately three months.

The Escalating Challenge of Feline Obesity

Statistics from the Association for Pet Obesity Prevention reveal a concerning trend: in 2022, nearly two-thirds of American cats were categorized as overweight or obese. A more recent survey in 2024 indicated that 33% of cat owners identified their pets as having weight issues, an increase from 28% in the previous year, highlighting the growing scale of this health concern.

Unveiling Akston's Innovative GLP-1 Therapy

The core of Akston's therapeutic strategy is a GLP-1 protein, meticulously engineered to assist cats in regulating their appetite. Prior preclinical investigations conducted at Cornell University, utilizing laboratory cats, demonstrated the therapy's safety, reporting no observed adverse reactions or unexpected incidents. Pharmacokinetic analysis further confirmed the suitability of a once-weekly dosage regimen for the treatment.

The Science Behind Extended Efficacy

This groundbreaking therapy is developed leveraging Akston's proprietary Fc-fusion protein platform. This advanced technological base enables the precise design, synthesis, and rigorous testing of therapeutics. A key advantage of this platform is its capacity to fine-tune interactions with the immune system, thereby extending the duration of the therapy's action and enhancing its effectiveness.

Addressing a Critical Unmet Need in Veterinary Medicine

Dr. Todd Zion, co-founder and CEO of Akston, emphasized the significant impact of feline obesity, noting it as one of the most prevalent yet inadequately treated health problems in veterinary practice. He stated that by advancing this once-weekly GLP-1 therapy, Akston is directly confronting a substantial unmet need, aspiring to improve cats' health and extend their lifespans.

Enrollment Underway: A Collaborative Effort for Future Pet Health

The clinical study is currently enrolling participants at Cornell University. Initially, the goal is to enlist 70 cats, with potential plans to expand enrollment to 140. Dr. Patrick Carney, Associate Professor of Clinical Sciences at Cornell University College of Veterinary Medicine, expressed his enthusiasm for the potential of this tool. He highlighted that it could represent a significant breakthrough for veterinarians by providing a safe and effective solution where none currently exists.

Expanding Horizons: GLP-1 Therapy for Canine Companions

Akston is not solely focused on feline health; the company is also developing a GLP-1 program for dogs. This canine-focused initiative is progressing approximately six months behind the feline program, indicating a broader commitment to addressing pet obesity across different species.

See More

Gelatin: A Revitalized Ingredient for Modern Pet Food Innovation

Gelatin, a protein derived from collagen, has historically been underutilized in pet food production due to certain processing difficulties. However, shifting consumer preferences towards high-protein, low-carbohydrate pet diets have prompted a renewed interest in this ingredient. Recent investigations indicate that gelatin's unique characteristics could offer significant advantages in contemporary pet food formulations, particularly in enhancing structural properties and expansion within extruded products.

Unlocking Gelatin's Potential in Pet Nutrition

Gelatin's Untapped Promise in Contemporary Pet Food

Despite past limitations related to its thermal characteristics, gelatin is now recognized for its considerable potential in modern pet food applications. Its distinct properties are well-suited to drive innovation, especially as the industry moves towards more specialized dietary requirements for pets. This renewed focus suggests a significant role for gelatin in future product development.

Overcoming Historical Processing Hurdles

Traditionally, gelatin's tendency to form a cold-set gel and its thermal reversibility (melting below 35℃) made it challenging to incorporate into standard pet food manufacturing processes such as extrusion and canning. These inherent properties presented a barrier to its widespread adoption in the past, leading to its limited use.

Positive Consumer Perception and Market Acceptance

Gelatin benefits from a generally favorable perception among pet owners, who are often familiar with its use in human food products. This positive public image could significantly aid in the marketing and acceptance of pet food products that include gelatin, making it an attractive ingredient for manufacturers.

Understanding Gelatin's Origin and Manufacturing Methods

Gelatin is sourced from animal byproducts, specifically bones and skins from pigs, cattle, or fish. Its production involves either acid (Type A) or alkali (Type B) processing methods, which dictate its final characteristics and suitability for various applications.

The Importance of Bloom Strength in Gelatin Functionality

The functional attributes of gelatin, particularly its gel firmness, are quantified by its bloom strength, which typically ranges from 50 to 300 grams. This metric is crucial for selecting the appropriate type of gelatin for specific formulation needs, ensuring optimal performance in the end product.

Current Niche Applications in Pet Food

Presently, gelatin's application in pet food is largely confined to specialized items like molded pet treats, such as dental chews, or as a visual gelling agent (aspic) in canned foods. In these uses, it primarily serves a textural or aesthetic purpose rather than contributing significantly to structural or functional integrity of the main meal.

Gelatin's Evolving Role in High-Protein Formulations

With a growing demand for high-protein, low-starch pet food, gelatin is gaining recognition as a valuable additive. It can help mitigate common issues in these formulations, such as insufficient kibble expansion and increased brittleness, thereby enhancing product quality.

Enhancing Kibble Structure and Durability

Research indicates that low-bloom gelatin can positively influence the expansion and overall durability of extruded pet food products. By interacting effectively with starch during the manufacturing process, gelatin contributes to a more robust and desirable kibble structure.

Re-evaluating Past Misconceptions

Previous unsuccessful attempts at using gelatin in pet food may have resulted from a mismatch between the product's requirements and the gelatin's specifications. Modern industry demands, coupled with a deeper understanding of gelatin's properties, now align more effectively with its functional benefits, warranting a re-evaluation of its utility.

Paving the Way for Future Innovations

Strategic deployment of various gelatin bloom strengths and a comprehensive understanding of their interaction with starch could unlock new avenues for innovation in pet food. This approach promises to lead to novel textures, diverse product shapes, and improved processing efficiencies, driving the industry forward.

See More